Bnp Paribas Asset Management Holding S.A. Protagonist Therapeutics, Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $37.3 Billion
- Q1 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 379,649 shares of PTGX stock, worth $20.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
379,649
Previous 125,898
201.55%
Holding current value
$20.6 Million
Previous $4.86 Million
277.76%
% of portfolio
0.05%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PTGX
# of Institutions
299Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$331 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$312 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$310 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$232 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$163 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.66B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...